Point72 Middle East FZE’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,241	Closed	-$450K	–	1262
2023 Q3	$450K	Buy	+14,241	New	+$450K	0.01%	432
2023 Q1	–	Sell	-480	Closed	-$16.7K	–	1468
2022 Q4	$16.7K	Buy	+480	New	+$16.7K	﹤0.01%	1124